Who
Peggy Wallace
Director
Company insider
Files Form 4 as: Director, Cognition Therapeutics.
In numbers
- Trades disclosed
- 12
- Buys
- 2
- Sells
- 0
- Bought
- $51K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 13 Oct 2021
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | CGTX Cognition TherapeuticsBiotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | CGTX Cognition TherapeuticsBiotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 18 Jun 2025filed 23 Jun 2025 | CGTX Cognition TherapeuticsBiotechnology | SEC FORM 4 Code A | —34,000 at $0.00 | filing |
| 7 Jun 2024filed 11 Jun 2024 | CGTX Cognition Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,500 at $0.00 | filing |
| 7 Jun 2024filed 11 Jun 2024 | CGTX Cognition TherapeuticsBiotechnology | SEC FORM 4 Code A | —8,500 at $0.00 | filing |
| 9 Jun 2023filed 13 Jun 2023 | CGTX Cognition Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 9 Jun 2023filed 13 Jun 2023 | CGTX Cognition TherapeuticsBiotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 15 Nov 2022filed 16 Nov 2022 | CGTX Cognition TherapeuticsBiotechnology | SEC FORM 4 Bought | $15K12,500 at $1.20 | filing |
| 27 Sep 2022filed 29 Sep 2022 | CGTX Cognition TherapeuticsBiotechnology | SEC FORM 4 Code J | —22,461 at $0.00 | filing |
| 10 Jun 2022filed 23 Jun 2022 | CGTX Cognition Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,335 at $0.00 | filing |
| 10 Jun 2022filed 13 Jun 2022 | CGTX Cognition Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,335 at $0.00 | filing |
| 13 Oct 2021filed 25 Oct 2021 | CGTX Cognition TherapeuticsBiotechnology | SEC FORM 4 Bought | $36K3,000 at $12.00 | filing |
News
Cognition Therapeutics (NASDAQ:CGTX) Stock Falls 2% – Here's WhyCGTX · dailypolitical.com · 10 Oct 2026
0 headlines in the last 90 days name Peggy Wallace; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.